Syngene International

BSE : 539268 | NSE : SYNGENE

Industry : Pharmaceuticals | ISIN : INE398R01022 | FreeFloat : 10.00% | FnO : Yes | LotSize : 850


Intellectual Capital (IC)5,584.25
Net Worth (NW)3,297.60
Intrinsic Worth (IW)8,881.85
Market Cap (MC)23,951.60
Economic Value Added30.40
Discount Rate%
Liquidity Premium%
Knowledge Basis (IC/IW)62.87%
IC Gross Margin (EBITDA/IC)17.26%
IC Net Margin (NPT/IC)9.68%
Knowledge Turnover (Sales/IC)0.51
Market to Intrinsic Value (MC/IW)2.70

As OfIntrinsic ValueMarket Price
31 Mar 2022Rs. 221.60Rs. 597.60
26 May 2022 ---- Rs. 528.45
0.50     0.09%
Fundamental - medium termTechnical - near termCombined outlook
EVA > 0 : YesBuy10 DMA : Rs. 544.20AccumulateBuy
KB > 50% : Yes50 DMA : Rs. 592.25
0 < M2IV < 1 : NoVol-Price trend : Rising

Question 3 - Is this stock undervalued?


Question 2 - Does this business have significant knowledge assets?


Question 1 - Is this business generating enough profits to cover its cost of capital?

* EVA is a registered trademark of Stern Stewart and Co.

Quarterly Results (Rs. Cr)
Quarter
Type*
Sales
Income
EBITDA
EBIT
PBT
PAT
NPT
Jun-19
C
420.90
441.40
121.10
73.70
87.10
72.00
72.00
Sep-19
C
464.60
485.20
139.20
86.60
170.10
128.10
128.10
Dec-19
C
519.10
539.10
153.50
96.50
106.70
91.80
91.80
Mar-20
C
607.30
627.80
86.90
24.60
15.30
12.02
-1.38
Jun-20
C
421.60
436.90
139.80
73.70
66.30
58.00
85.30
Sep-20
C
519.60
533.40
169.50
100.80
94.20
84.10
93.35
Dec-20
C
584.50
601.60
193.30
123.60
116.50
102.20
141.80
Mar-21
C
658.60
677.00
268.80
198.80
192.20
160.60
194.80
Jun-21
C
594.50
606.80
177.30
102.60
94.70
77.30
62.20
Sep-21
C
610.20
623.10
159.60
83.40
82.20
66.70
98.60
Dec-21
C
641.40
654.30
216.30
137.80
128.40
104.00
122.50
Mar-22
C
758.10
772.80
265.00
184.70
179.10
147.80
148.00
* C - Consolidated, S - Standalone